Minimizing Ischemia Reperfusion Injury in Xenotransplantation

Front Immunol. 2021 Sep 9:12:681504. doi: 10.3389/fimmu.2021.681504. eCollection 2021.

Abstract

The recent dramatic advances in preventing "initial xenograft dysfunction" in pig-to-non-human primate heart transplantation achieved by minimizing ischemia suggests that ischemia reperfusion injury (IRI) plays an important role in cardiac xenotransplantation. Here we review the molecular, cellular, and immune mechanisms that characterize IRI and associated "primary graft dysfunction" in allotransplantation and consider how they correspond with "xeno-associated" injury mechanisms. Based on this analysis, we describe potential genetic modifications as well as novel technical strategies that may minimize IRI for heart and other organ xenografts and which could facilitate safe and effective clinical xenotransplantation.

Keywords: ex vivo perfusion; initial xenograft dysfunction; ischemia reperfusion (I/R) injury; ischemia reperfusion injury mechanisms; ischemia reperfusion injury minimization; xenotranplantation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptive Immunity
  • Animals
  • Biomarkers
  • Complement System Proteins / immunology
  • Complement System Proteins / metabolism
  • Disease Management
  • Disease Susceptibility
  • Heterografts
  • Humans
  • Immunity, Innate
  • Mitochondria / immunology
  • Mitochondria / metabolism
  • Organ Specificity
  • Organ Transplantation* / adverse effects
  • Oxidative Stress
  • Reactive Oxygen Species / metabolism
  • Reperfusion Injury / etiology
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / prevention & control*
  • Transplantation, Heterologous

Substances

  • Biomarkers
  • Reactive Oxygen Species
  • Complement System Proteins